PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15166004-2 2004 We postulated that intraduodenal administration of lauric acid (12 carbon atoms; C12) would suppress appetite, modulate antropyloroduodenal pressure waves (PWs), and stimulate the release of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) more than an identical dose of decanoic acid (10 carbon atoms; C10). lauric acid 51-62 cholecystokinin Homo sapiens 191-206 17331985-2 2007 We postulated that, in humans, the modulation of antropyloroduodenal pressure waves, plasma cholecystokinin (CCK) and peptide YY (PYY) concentrations and energy intake by intraduodenal lauric acid, a fatty acid with 12 carbon atoms ("C12") would be load, but not concentration, dependent. lauric acid 185-196 cholecystokinin Homo sapiens 109-112 15961531-1 2005 We recently reported that intraduodenal infusion of lauric acid (C12) (0.375 kcal/min, 106 mM) stimulates isolated pyloric pressure waves (IPPWs), inhibits antral and duodenal pressure waves (PWs), stimulates release of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1), and suppresses energy intake and that these effects are much greater than those seen in response to isocaloric decanoic acid (C10) infusion. lauric acid 52-63 cholecystokinin Homo sapiens 220-235 15961531-1 2005 We recently reported that intraduodenal infusion of lauric acid (C12) (0.375 kcal/min, 106 mM) stimulates isolated pyloric pressure waves (IPPWs), inhibits antral and duodenal pressure waves (PWs), stimulates release of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1), and suppresses energy intake and that these effects are much greater than those seen in response to isocaloric decanoic acid (C10) infusion. lauric acid 52-63 cholecystokinin Homo sapiens 237-240 15166004-2 2004 We postulated that intraduodenal administration of lauric acid (12 carbon atoms; C12) would suppress appetite, modulate antropyloroduodenal pressure waves (PWs), and stimulate the release of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) more than an identical dose of decanoic acid (10 carbon atoms; C10). lauric acid 51-62 cholecystokinin Homo sapiens 208-211 14764444-2 2004 Fatty acid release of CCK is chain-length sensitive; dodecanoic acid (C12) induces greater CCK release than decanoic acid (C10). lauric acid 53-68 cholecystokinin Homo sapiens 22-25 14764444-2 2004 Fatty acid release of CCK is chain-length sensitive; dodecanoic acid (C12) induces greater CCK release than decanoic acid (C10). lauric acid 53-68 cholecystokinin Homo sapiens 91-94 9782155-5 1998 Dodecanoic acid (C12) was most effective, producing up to a 5-fold increase in CCK secretion. lauric acid 0-15 cholecystokinin Homo sapiens 79-82